Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

377.61 -2.12 (-0.56%)

Streaming Delayed Price Updated: 1:23 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

64 65 Next >

Wall Street Recovers, Apple Rallies 6% On $100-Billion Gov Manufacturing Investment: What's Moving Markets Wednesday? ↗

August 06, 2025

U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.

Via Benzinga

RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program ↗

August 06, 2025

Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue.

Via Benzinga

Topics Lawsuit

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Uncovering Potential: Amgen's Earnings Preview ↗

August 04, 2025

Via Benzinga

What Analysts Are Saying About Amgen Stock ↗

July 21, 2025

Via Benzinga

This Is What Whales Are Betting On Amgen ↗

July 21, 2025

Via Benzinga

Amgen Delivers Beat And Raise Quarter; Has Strong Late-Stage Pipeline ↗

August 06, 2025

Amgen reported total revenue of $9.2 billion, topping the consensus of $8.9 billion, and non-GAAP earnings of $6.02 per share.

Via Benzinga

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

August 06, 2025

Via Investor Brand Network

Topics Government

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

August 06, 2025

EQNX::TICKER_START (NASDAQ:SNGX),(NASDAQ:FOLD),(NASDAQ:TNXP),(NASDAQ:CTOR),(NASDAQ:AMGN) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Government

What Does the Market Think About Amgen? ↗

July 11, 2025

Via Benzinga

AMGEN INC (NASDAQ:AMGN) Shows Strong Technical Breakout Potential with High Setup Rating ↗

August 06, 2025

AMGEN INC (AMGN) shows strong breakout potential with a Technical Rating of 7 and Setup Rating of 9, signaling bullish momentum and a tight consolidation pattern.

Via Chartmill

Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country' ↗

August 06, 2025

President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far.

Via Benzinga

Topics Government World Trade

Amgen (AMGN) Q2 Profit Jumps 21% ↗

August 05, 2025

Via The Motley Fool

Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue

August 05, 2025

Biotech company Amgen (NASDAQ:AMGN) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.4% year on year to $9.18 billion. The company expects the full year’s revenue...

Via StockStory

Amgen Inc (NASDAQ:AMGN) Surpasses Q2 2025 Earnings Estimates Despite Muted Market Reaction ↗

August 05, 2025

Amgen beats Q2 2025 earnings with $9.179B revenue and $6.02 EPS, but shares dip slightly as market reaction remains muted. CEO highlights growth in biosimilars and raised full-year guidance.

Via Chartmill

Will Amgen, Already Above Its 50-Day Line, Break Out On This Earnings News? ↗

August 05, 2025

Amgen crushed second-quarter forecasts late Tuesday. The news could push Amgen stock into a breakout.

Via Investor's Business Daily

Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday? ↗

August 05, 2025

Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc.

Via Benzinga

Topics Economy Government

Stock Market Today: US Stock Futures Inch Higher, As Analysts Warn of Volatile August—AMD, Pfizer, Caterpillar In Focus ↗

August 05, 2025

U.S. stock futures are inching higher on Tuesday, following a strong rally on Monday, with major benchmark indices in the green.

Via Benzinga

Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow

August 03, 2025

Via StockStory

Topics Artificial Intelligence World Trade

Nuclear Threats, Trump Fires Labor Statistics Chief, Fed Governor Resigns And More: This Week In Politics ↗

August 03, 2025

Via Benzinga

Topics Economy Government

Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...' ↗

August 01, 2025

President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences.

Via Benzinga

Topics Government

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial ↗

July 31, 2025

Soligenix reports positive Phase 2a trial results for SGX945 in Behçet's disease, showing strong efficacy and no adverse events compared to apremilast.

Via Benzinga

2 Top Dividend Stocks to Buy Right Now and Hold Forever ↗

July 28, 2025

Long-term shareholders have already seen significant gains from these stocks, and there's likely much more to come for patient investors.

Via The Motley Fool

Topics Intellectual Property

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

July 25, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate ↗

July 24, 2025

AstraZeneca's gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR antibody-positive gMG.

Via Benzinga

2 Reasons to Like AMGN and 1 to Stay Skeptical

July 24, 2025

Amgen’s 11.6% return over the past six months has outpaced the S&P 500 by 7.3%, and its stock price has climbed to $307.50 per share. This was partly due to its solid quarterly results, and the run-up...

Via StockStory

Topics Government Stocks

Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest

July 16, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Amgen (NASDAQ:AMGN) and the...

Via StockStory

Topics Artificial Intelligence

July 15, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

How Does Nvidia's Reaching $4 Trillion in Market Cap Impact the S&P 500, Nasdaq-100, and Dow Jones? ↗

July 14, 2025

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.